HOME >> MEDICINE >> NEWS
Co-occurring disorders increase risk of suicide attempt by adolescents

Research has shown that adolescents with substance use disorders are most likely to attempt suicide when they also have a co-occurring mood disorder. NIDA-funded scientists at the University of Pittsburgh have extended this research and found that generally, both male and female substance abusers who attempt suicide begin taking drugs at an early age and have more symptoms of psychiatric and substance use disorders than adolescents who do not attempt suicide.

Dr. Thomas Kelly and colleagues collected data from 188 females and 315 males, aged 12 to 19 years, who were diagnosed with an alcohol or substance use disorder and who participated in studies between 1991 and 2000 at the Pittsburgh Adolescent Alcohol Research Center. The adolescents completed standardized assessments of substanceand nonsubstance-related psychiatric disorders. Both the adolescents and their parents answered standardized questions about age of onset for all diagnosed psychiatric disorders. Adolescents who attempted suicide and their parents estimated the age(s) at which the adolescent attempted suicide.

Overall, 29 males and 56 females made one or more suicide attempts during their lifetimes. Males with hallucinogen use disorders, inhalant use disorders, sedative-hypnotic use disorders, and attention-deficit hyperactivity disorder were more likely to have attempted suicide than males who were not diagnosed with these disorders. Male suicide attempters had more symptoms of mood, alcohol, and disruptive behavior disorders compared with male nonattempters. There existed an earlier age of onset for alcohol use disorders and conduct disorders among male suicide attempters compared with the age of onset among males with these disorders who did not attempt suicide.

Females with conduct disorders and substance use disorders (other than cannabis use disorders) were at higher risk for attempting suicide than females who were not diagnosed with conduct disorders or noncannabis subst
'"/>

Contact: Blair Gately
bgately@nida.nih.gov
301-443-6245
NIH/National Institute on Drug Abuse
3-May-2004


Page: 1 2

Related medicine news :

1. New self-help technology set to combat eating disorders
2. Diagnostic test for range of blood disorders on the horizon
3. Dental practitioners can be instrumental in preventing their patients eating disorders
4. Psychiatric disorders greatly underdiagnosed in hospital emergency departments
5. Newly discovered virus linked to childhood lung disorders and Kawasaki disease
6. Drug to treat ADHD has similar effect on children with reading disorders
7. Gastrointestinal disorders are associated significantly with sleepless nights
8. Immigration & psychiatric disorders
9. Diabetics with mental disorders at increased risk for diabetic complications
10. Canadian researchers to develop smart drug to repair psychiatric disorders
11. Nicotine dependence & psychiatric disorders

Post Your Comments:
(Date:4/17/2014)... One of the most popular vaccine brands for children ... may be overlooking some cost factors when choosing vaccines, ... expensive option, according to a new study by University ... administer can be driven by numerous factors," says Sheldon ... professor of computer science and of mathematics at the ...
(Date:4/17/2014)... of California, San Diego School of Medicine report that ... a recent major loss are more likely to be ... study is published in this month,s issue of the ... compassionate behaviors are associated with better health and well-being ... ways to improve the outcomes of individuals whose deficits ...
(Date:4/17/2014)... Jon McCullers, MD, was recently invited to submit ... Nature Reviews Microbiology , one of the world,s ... infectious disease specialist, and chair of the Department ... Science Center, analyzed the epidemiology and microbiology of ... as well as more recent 2009 novel H1N1 ...
(Date:4/17/2014)... MAYWOOD, Il. (April 17, 2014) Doctors who ... disease called lymphangioleiomyomatosis (LAM) can face an agonizing ... progression of the disease and help relieve shortness ... lung transplants, and sirolimus can cause potentially fatal ... said pulmonologist Dr. Daniel Dilling, medical director of ...
(Date:4/17/2014)... 17, 2014-- Colic affects about one in five infants ... pediatric visits during the first several months after birth. ... was showing promise; however, the April 1, 2014 issue ... Valerie) reported on a study, "Probiotics and Infant Colic," ... reuteri for infant colic did not reduce ...
Breaking Medicine News(10 mins):Health News:Study recalculates costs of combination vaccines 2Health News:The ilk of human kindness 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Drug Delivery Systems -- Focus on End ... STUDY OBJECTIVES A drug ...
(Date:1/15/2014)... 15, 2014  Zafgen, Inc., a leading biopharmaceutical company ... obese patients, today announced initial results from its ... of methionine aminopeptidase 2 (MetAP2), in patients with ... obesity.  These results showed improvements in body weight, ...
(Date:1/14/2014)... HeartWare International, Inc . (NASDAQ: ... circulatory support technologies that are revolutionizing the treatment of ... for the fourth quarter of 2013 will be approximately ... $208 million. "Our full-year revenue growth of ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4
Cached News: